Skip to main content
$290.07 $1.53 (0.5%)

10:46 AM EDT on 08/14/20

Biogen Inc (NASDAQ:BIIB)

CAPS Rating: 4 out of 5

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

Current Price $290.07 Mkt Cap $46.4B
Open $287.99 P/E Ratio 8.46
Prev. Close $288.54 Div. (Yield) $0.00 (0.0%)
Daily Range $287.79 - $290.50 Volume 144,253
52-Wk Range $215.78 - $374.99 Avg. Daily Vol. 1,634,207

Caps

How do you think NASDAQ:BIIB will perform against the market?

Add Stock to CAPS Watchlist

All Players

984 Outperform
75 Underperform
 

All-Star Players

200 Outperform
15 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BIIB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

sojournerks (97.26)
Submitted October 27, 2018

Good company in promising sector

JorgeAura (26.90)
Submitted February 02, 2013

Nasdaq in maximums.

Recent Community Commentary

Read the most recent pitches from players about BIIB.

Recs

0
Member Avatar tomfoolme (57.36) Submitted: 7/27/2020 8:56:40 PM : Underperform Start Price: $282.68 NASDAQ:BIIB Score: +1.97

Down thumb. C19 has none esensual medical on hold. And it is down to 3 stars. Mostly a watch for bottom

Recs

0
Member Avatar TMFacarchidi (37.18) Submitted: 7/16/2020 10:43:25 AM : Underperform Start Price: $278.17 NASDAQ:BIIB Score: +0.96

Few compelling pipeline projects will come to fruition for the rest of this year, and performance so far has been mediocre.

Recs

0
Member Avatar tiomiguel (40.32) Submitted: 5/20/2020 5:07:37 PM : Outperform Start Price: $311.58 NASDAQ:BIIB Score: -20.57

Solid earnings and free-cash growth; well-positioned in auto-immune pharmaceuticals.

Leaderboard

Find the members with the highest scoring picks in BIIB.

Score Leader

optioncoach

optioncoach (94.59) Score: +637.71

The Score Leader is the player with the highest score across all their picks in BIIB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
fwhittlesey < 20 4/12/2007 Outperform 3Y $43.64 +563.15% +147.47% +415.68 1 Comment
anewday101 91.29 3/5/2007 Outperform 1Y $43.36 +567.44% +158.92% +408.51 0 Comment
tradersinsights 70.97 4/10/2007 Outperform 1Y $44.42 +551.51% +146.16% +405.35 1 Comment
ambina < 20 3/12/2007 Outperform NS $43.95 +558.48% +153.55% +404.92 0 Comment
mtung 39.77 3/8/2007 Outperform NS $44.10 +556.24% +154.10% +402.13 0 Comment
gliberty < 20 8/22/2006 Outperform 5Y $42.68 +578.07% +176.32% +401.75 1 Comment
apple1jam 75.22 3/6/2007 2/27/2008 Outperform NS $43.94 +558.63% +157.32% +401.30 0 Comment
owen1000 79.70 8/22/2006 Outperform 3Y $42.83 +575.69% +175.93% +399.77 0 Comment
nickysone 69.10 4/9/2007 Outperform 3Y $44.86 +545.12% +145.92% +399.20 1 Comment
mgroeber < 20 4/9/2007 Outperform NS $44.86 +545.12% +145.92% +399.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BIIB.